- Home
- ONFO vs ADIL Comparison
ONFO vs ADIL Comparison
Compare ONFO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- ADIL
- Stock Information
- Founded
- ONFO 2018
- ADIL 2010
- Country
- ONFO United States
- ADIL United States
- Employees
- ONFO N/A
- ADIL N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- ADIL Health Care
- Exchange
- ONFO Nasdaq
- ADIL Nasdaq
- Market Cap
- ONFO 5.4M
- ADIL 6.0M
- IPO Year
- ONFO 2022
- ADIL 2018
- Fundamental
- Price
- ONFO $1.04
- ADIL $0.39
- Analyst Decision
- ONFO
- ADIL Strong Buy
- Analyst Count
- ONFO 0
- ADIL 1
- Target Price
- ONFO N/A
- ADIL $8.00
- AVG Volume (30 Days)
- ONFO 57.3K
- ADIL 4.0M
- Earning Date
- ONFO 08-14-2025
- ADIL 08-13-2025
- Dividend Yield
- ONFO N/A
- ADIL N/A
- EPS Growth
- ONFO N/A
- ADIL N/A
- EPS
- ONFO N/A
- ADIL N/A
- Revenue
- ONFO $10,508,728.00
- ADIL N/A
- Revenue This Year
- ONFO N/A
- ADIL N/A
- Revenue Next Year
- ONFO N/A
- ADIL N/A
- P/E Ratio
- ONFO N/A
- ADIL N/A
- Revenue Growth
- ONFO 78.36
- ADIL N/A
- 52 Week Low
- ONFO $0.61
- ADIL $0.22
- 52 Week High
- ONFO $1.88
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- ONFO 45.84
- ADIL 45.40
- Support Level
- ONFO $0.94
- ADIL $0.38
- Resistance Level
- ONFO $1.26
- ADIL $0.42
- Average True Range (ATR)
- ONFO 0.11
- ADIL 0.06
- MACD
- ONFO -0.02
- ADIL -0.01
- Stochastic Oscillator
- ONFO 27.75
- ADIL 10.73
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.